Healthcare_research

Accounting software is a computer software especially designed for accounting professionals to manage accounts and perform day to day accounting operations. Accounting is asystematized practice, work or process of communicating and tracking financial data. A business organization apply accounting software in their day to day accounting practices for different purposes including internal and external audits, required reports and financial analysis to comply legal or internal managerial requirements. There are various types of accounting software including simple and easy, single-entry programs for individual record-keeping to more urbane, double-entry systems that can process and track accounts receivable, accounts payable, payroll and inventory, among other features and functions.

Accounting software is a vital tool for any business. It helps a business manager run the business efficiently and profitably. With the arrival of cloud computing and automations, bookkeeping too has undergone many changes over the last one decade. We can witness changes happening in the global business environment every now and then. And thus, it is necessary to be updated with such rapid changes.

In current times, innovations and technology have become an important part of the accounting and bookkeeping industry. The new accounting facts and trends recommend that many things can now be completed by brief off-site meetings, and with a variety of software options, one can have better visibility and accountability of business goals. The current trends in accounting have exceeded the outdated methods of financial management, absence of real-time data, and the basic desktop-based software as well.

A well-run accounting function can build the base of a successful enterprise, and if the right strategies and practices are followed, your enterprise can sustain the rigorous competition and be one step ahead of the competition.

Key accounting trends of 2020 that can impact the complete accounting software industry:

1. Cloud Computing

Cloud computing is one of the trending technologies that is not showing signs of slowing down. According to a study by North Bridge (venture capital firm), approximately 75% of IT managers and senior executives stated that they were using at least a single cloud-based business application.

What’s attracting towards cloud? A cloud approach is a powerful choice for companies who are seeking to outsource software and hardware support for reducing costs and focusing on core competencies. Cloud-based options also let a simple extension of system access to branch offices and remotely active users. This capability for direct access to systems with just a web browser and consistent internet connectivity is helpful in another core benefit which is ability to use business systems and data, anywhere, any time.

Cloud-based technology is going to gain a stronger momentum in accounting trends in the current scenario and impact different areas of business now and in the future. With the advantages of shared resources, server run accounting software models and easily accessible financial information through the cloud will make accounting processes more effective.

2. Comprehensive Functionality

A study of modern accounting software discloses that they typically include many applications and modules that go beyond the conservative definition of‘accounting software.’ The present accounting software is expected to include functionalities for supporting manufacturing, sales, inventory management, as well as other business domains.

Single systems additionally offer a consistent data set such that real-time changes in one system are replicated in other systems. A single data record can help improve transparency and get rid of bottlenecks in multiple departments.

3. Online Support for Implementation

Due to the complexity in accounting software, user may sometime need additional assistance from technical specialists for proper configuration, installation, and support. But with the convenience of widespread broadband connectivity, a user is not limited to a specific geographical location to seek assistance. This access to online support suggests that the users have the option to choose from a range of support options.

4. Mobile Accounting

The remotely located workforce is now a common phenomenon in many enterprises. To ensure that team members can get a task done on the go, it is important have mobile accounting applications in place. Mobile accountancy is essential because automated documentation is slowly replacing paper-based invoices and payment receipts, which is being widely accepted as well. Therefore, integrating automated mobile technology in your accounting processes can be a win-win situation for your valued clients as well as your team members.

5. Analytics and Reporting

It’s been a practice for quite some time now to use data for guiding strategic decision making. But the emphasis of business intelligence tools in accounting software is a new trend. One can now can measure the impact of business analytics tools on the performance of business. The integration of analytic tools in accounting software can help users to make future strategies on specific issues such as where and how to invest, where expenses are higher than expected and how to control them.

Additionally, enterprises are seeking for features that could generate financial reports, such as balance sheets, cash flow statements, profit and loss reports, etc in a professional and presentable manner. Eventually, this data is vital to make smart financial and management decisions.

Accounting has surelystepped into its golden age with theadvent of these new trends into bookkeeping.

Conclusion

As new technologies continue to transform the way businesses run and function, holding on to traditional methods of accountancy practices could leave you back in the growing competition.

Accounting is not going to be any easier in the future. Therefore, it is important to adapt new technology and new trends in accounting to improve business efficacy. In the growing business environment, adapting the right technological developments in accounting will contribute towards your decision-making ability and the overall success of your enterprise.

Read More in Detailed: https://www.360quadrants.com/software/accounting-software

According to the new market research report “Orthopedic Braces and Supports Market by Product (Knee, Ankle, Hip, Spine, Shoulder, Neck, Elbow, Hand, Wrist), Category (Soft, Hard, Hinged), Application (Ligament (ACL, LCL), Preventive, OA), Distribution (Hospital) & Region – Global Forecast to 2025″, published by MarketsandMarkets™, is estimated to be USD 3.1 billion in 2020 and projected to reach USD 4.1 billion by 2025, at a CAGR of 5.8 %.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=24806829

The Increasing prevalence of orthopedic diseases & disorders, continuous product commercialization, greater product affordability & market availability, rising number of sports and accident-related injuries, and growing public awareness related to preventive care are the key factors driving the growth of the orthopedic braces and supports industry.

The otc braces and supports market includes major Tier I and II suppliers like DJO Finance LLC (US), Össur Hf (Iceland), Breg, Inc. (US), Bauerfeind AG (Germany), and DeRoyal Industries, Inc. (US). These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. Demand for orthopedic braces and supports from key end-users has significantly declined amidst the global COVID-19 pandemic. Industry experts believe that COVID-19 will have short-term negative growth for the orthopedics and supports market in 2020, but will experience normal growth as the market gradually steadies by the end of 2020.

Browse in-depth TOC on “Orthopedic Braces and Supports Market”
280 – Tables
30 – Figures 
374 – Pages

Demand for knee braces and supports among medical professionals and athletes is expected to result in the segment occupying the majority of the market share

The knee braces and supports market is estimated to have the largest market share by value. Growth of this segment can be attributed to the growing demand for knee braces & supports among medical professionals and athletes and favorable reimbursement scenario for knee braces in developed countries. Moreover, growing geriatric & obese population (which are at a higher risk of developing osteoarthritis and other knee-related conditions), and the increasing number of sports injuries is expected to drive the market growth.

Lower spine braces estimated to be the largest and fastest-growing market

Lower spine braces are estimated to be the largest and fastest-growing segment in the Orthopedic Braces And Supports Market. The growth of this segment can be attributed to the rising incidence of lower spine disorders and the growing number of hip & disc replacement surgeries (which utilize lower spine braces and supports for post-operative rehabilitation).

North America is estimated to be the largest market due to the continuous development and commercialization of novel orthopedic braces & support products, favorable reimbursements & insurance coverage for major orthopedic bracing procedures, supportive government regulations for product commercialization, and significant sports participation.

Get 10% Customization on this Research Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=24806829

Asia Pacific likely to emerge as the largest Orthopedic Braces And Supports Market, globally

Asia Pacific is estimated to be the fastest-growing market for orthopedic braces and supports during the forecast period. The Asia Pacific market is driven principally by the rising geriatric and obese population (coupled with the significant prevalence of orthopedic & diabetes-related diseases in this population segment), increasing GDP and healthcare expenditure in APAC countries, and growing public awareness. Furthermore, increasingly localized product manufacturing, favorable government regulations, and the focus of global product manufacturers on expanding their presence in APAC countries are aiding the market growth.

DJO Finance LLC (US), Össur Hf (Iceland), Breg, Inc. (US), Bauerfeind AG (Germany), and DeRoyal Industries, Inc. (US)  are the key players in the global Orthopedic Braces And Supports Market.

The research study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

How the market Growth Impact in terms of revenue?

The Global Diabetes Care Devices Market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.

Diabetes Care Devices Market, Growth Factor Analysis:

·        Sharp increase in diabetes in the past decade

·        Favorable national health strategies

·        Government-LED endorsement of the medical device industry

·        Diabetes awareness campaigns

·        Increasing penetration of smartphones and rising focus on digital health

Speak to Our Research Analyst, to resolve your Queries: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=375

Blood Glucose Monitoring System Estimates to Dominate the Growth of the market.

Insulin Delivery Devices, and diabetes management mobile applications. Under the blood glucose monitoring systems segment, the test strips segment is estimated to account for the largest share in 2020. The dominance of this segment can be attributed to the frequent requirement of test strips in blood glucose monitoring systems.

Self/Home Healthcare Is Projected To Witness the Highest CAGR Growth.

The rapid growth of the segment is attributed to the increasing awareness of diabetes self-monitoring and management, increasing recommendations from physicians for home healthcare for diabetes, and the increasing utility of home-based diabetes care devices to provide real-time insights regarding the condition due to the technological advancements of these systems.

Objectives of the Study in Depth;

·  To define, describe, and forecast the diabetes care devices market by type, end user, and country

· To provide detailed information about the factors influencing the market growth (such as drivers, opportunities, restraints, and challenges)

·  To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall diabetes care devices (BRIC) market

·  To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

·  To forecast the size of the diabetes care devices market in Brazil, Russia, India, and China

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375

China is projected to hold the largest share in the diabetes care devices (BRIC) market during the forecast period. This can be attributed to the sharp increase in diabetes in the country, favorable national health strategies, and government-led endorsements of medical device companies.

The prominent players in the diabetes care devices market include Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation (Japan), SD Biosensor, Inc. (South Korea), MicroGene Diagnostic Systems Pvt. Ltd. (India), Ypsomed Holdings AG (Switzerland), Dr. Morepen (India), Sinocare, Inc. (China), Bionime Corporation (Taiwan), and Rossmax International Ltd. (Taiwan).

Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics. The major drivers for the market are rapid growth in pharmaceutical and biotechnology industries and strong trend of R&D investments in life sciences industry.

According to the new market research report “Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) – Global Forecast” published by MarketsandMarkets™.

The Global Viral Inactivation Market poised to grow at a CAGR of 12.3%, to reach USD 573.0 Million.

Major Market Growth Drivers:

• - Rapid Growth in Pharmaceutical and Biotechnology Industries
• - Increasing Number of New Drug Launches
• - Strong R&D Investments in the Life Sciences Industry
• - Increasing Government Support for Pharmaceutical and Biotechnology Industries
• - High Incidence and Large Economic Burden of Chronic Diseases
  
  

Browse 72 market data tables with 70 figures spread through 154 pages and in-depth TOC – Request Research Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017

 

Market Segmentation in Depth:

By method, the market is divided into solvent detergent method, pasteurization, and other methods. Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light. Of these, the solvent detergent method segment accounted for the largest share of the global viral inactivation market.

The application segments included in this report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics. Of these the vaccines and therapeutics application hold the highest share.

By end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users. Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121427017

Major players in the viral inactivation market include Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China).

Accounting software is a computer software especially designed for accounting professionals to manage accounts and perform day to day accounting operations. Accounting is a systematized practice, work, or process of communicating and tracking financial data. A business organization requires accounting software in their day-to-day accounting practices for various purposes including internal and external audits, reports, and financial analysis to comply with legal or internal managerial requirements. There are different kinds of accounting software including simple and easy, single-entry programs for individual record-keeping to more urbane, double-entry systems that can process and track account receivables, account payables, payroll and inventory, among other features and functions.

Best Accounting Software for medium sized businesses offers the right tools that businesses and their teams require to become more productive and discover new ways to grow their businesses. With the instinctive mobile app, it enables sending invoices, track expenses, and connect with customers, all from the convenience of using mobile phones or tablets. Time management tools provided by the software enable tracking the time spent to make invoicing simpler and easier. This helps in getting all the information required within the stipulated time period for taxation purposes.

Key Features of the best Accounting Software

Auto-billing Capability -

Best accounting software enables setting up a billing schedule helping automatically charge subscription-based and recurring clients. It also secures all client card information and receive payments within seconds

Late Payment Reminders

To avoid constant late payments that slows down businesses, the software enables the creation of automatic reminders to gently push clients with emails when invoices are overdue. It also has default settings, or can manually customize messages to meet business needs.

Time Tracking -

It facilitates managing the time spent by the team on projects without leaving the software tool. The software permits each person to start a timer when they commence work and track the time it is completed. This enables providing with accurate time logs for projects. Once the project is completed, the time logs can be extracted to invoices and delivered to client inboxes. The time tracking tools can also be used to enhance productivity for all, enabling viewing information in real-time.

Simple Financial Reports and Analysis

Analysis and reporting are one of the key features a best accounting software must possess. Report recording and maintaining is a key requirement of any business to analyze and report under critical financial conditions. Easy and quick access to records enable organizations to efficiently enable major tasks and meetings. The analyses and reports are useful for managements to make key decisions and save time and stress.

Creates Estimation –

Early and advance estimates help businesses and their clients work on common ground so that planning becomes easier. The software provides estimates in just a few clicks that can be accessed by their clients as well. This helps clients review estimates and accept them.

Effective Collaboration Tool –

Best accounting software transforms the overall accounting experience. The software provides access to project management and team collaboration tools without leaving the software. It also allows inviting employees and clients where everyone can view and update project data based on their roles. The cloud-based accounting software makes it simple and convenient for everyone to work with the most up-to-date information and share ideas within seconds.

ABOUT 360QUADRANTS:

360Quadrants is the largest marketplace looking to disrupt USD 3.7 trillion of technology spends and is the only rating platform for vendors in the technology space. The platform provides users access to unbiased information that helps them make qualified business decisions. The platform facilitates deeper insight using direct engagement with 650+ industry experts and analysts and allows buyers to discuss their requirements with 7500 vendors. Companies get to win ideal new customers, customize their quadrants, decide key parameters, and position themselves strategically in a niche space, to be consumed by giants and start-ups alike. Experts get to grow their brand and increase their thought leadership. The platform targets the building of a social network that links industry experts with companies worldwide. The platform has around 400 total buyers across various markets.

360Quadrants will also be launching quadrants in fields like Project management software, Embedded Systems, and Virtual Machine Software.

Contact:

Mr. Agney Sugla
agney@marketsandmarkets.com
630 Dundee Road, Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441

According to the new market research report “In Vivo Toxicology Market by Product (Instruments, Consumables (Animal models, Reagents & Kits)), Testing type (Chronic, Sub-chronic), Toxicity Endpoints (Immunotoxicity, Systemic, DART), Testing Facility (Outsourced, In-house) – Global Forecast” published by MarketsandMarkets™.

The In Vivo Toxicology Market is expected to reach USD 6.14 Billion, at a CAGR of 6.9%.

Objectives of the Study;

To define, describe, and forecast the global market by product, testing type, toxicity endpoint, testing facility, and region

• To provide detailed information regarding the major factors influencing the growth of the global market (drivers, restraints, opportunities, and challenges)
• To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East Africa

Browse 124 tables and 38 figures spread through 196 pages and in-depth TOC – Request Research Sample Pages: 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=105308811

 

Major Market Growth Drivers:

• Increasing Pharmaceutical R&D Activities
• Mandatory Government Regulations for Animal Testing
• Innovations in Animal Models
• Exclusive In Vivo Toxicology Tests
• Increasing Research in Oncology and Personalized Medicine

The consumables segment is expected to hold the largest share of the market

Based on product, the in vivo toxicology market is segmented into consumables and instruments. The consumables segment is further divided into reagents & kits and animal models. In 2017, the consumables segment is expected to account for the largest share of the in vivo toxicology market owing to the increasing R&D funding for the development of new transgenic animal models, advancements in the development of genetically modified animals, increasing usage of reagents and kits for biological sample analysis.

By testing type, sub-acute toxicity testing to register the highest CAGR during the forecast period

The in vivo toxicology market is segmented by testing type into chronic, sub-chronic, sub-acute, and acute toxicology testing. In 2017, the sub-acute toxicity testing segment is expected to register the highest CAGR of during the forecast period. Growth in this market is attributed to the increasing focus on neurological and anti-viral drug research, which requires more than two weeks of toxicity studies.

Download PDF Brochure: 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105308811

The US is estimated to account for the largest share of the in vivo toxicology market, followed by Germany and the UK. However, China is expected to grow at the highest CAGR during the forecast period. Factors such as rising R&D funding and collaborations; initiatives by the Chinese government to promote life science research; and the strong trend of commercialization of biotechnology research are contributing to the growth of the in vivo toxicology market in China.

The major players in the global in vivo toxicology market include Thermo Fisher (US), Danaher (US), Charles River (US), Covance (LabCorp), and The Jackson Laboratory (US).

According to the new market research report “Collagen and Gelatin Market for Regenerative Medicine (by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopedic, Cardiovascular)), Value and Volume Analysis – Global Forecast” published by MarketsandMarkets™.

How the Market Growth looks like and Industry Segmentation?

The Global Collagen Market for Regenerative Medicine is projected to reach $679.9 Million, at a CAGR of 10.1% during the forecast period.

The Global Gelatin Market for Regenerative Medicine is projected to reach $94.9 Million, at a CAGR of 7.8% during the forecast period.

By source, the global collagen market for regenerative medicine has been segmented into bovine collagen, porcine collagen, marine collagen, and other sources. The bovine collagen segment is expected to command the largest share of the global collagen market for regenerative medicine. The large share of this segment is attributed to the lower cost and extensive availability of bovine collagen.

On the basis of application, the global collagen market for regenerative medicine has been segmented into orthopedic, wound care, cardiovascular, and other applications. The orthopedic applications segment is expected to command the largest share of the global collagen market for regenerative medicine. The large share of this segment can primarily be attributed to the high prevalence of osteoporosis.

Browse 155 Market Data Tables and 48 Figures spread through 177 Pages and in-depth TOC – Request Research Sample Pages: 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=95663122

Major Market Growth Drivers:

• Availability of Government and Private Funding for R&D
• Rising Prevalence of Chronic Diseases
• Rapid Growth in Aging Population
• Increasing Research on Collagen and Gelatin-Based Products

Objectives of the Study

• To define, describe, and forecast the global collagen and gelatin market for regenerative medicine by source, application, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
• To analyze micromarkets with respect to the individual growth trends, prospects, and contributions to the overall market
• To profile the key players and comprehensively analyze their product portfolios, and core competencies in the global collagen and gelatin market for regenerative medicine

Download PDF Brochure: 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95663122

Geographical Regions Mapped in Report:

North America is expected to account for the largest share of the collagen market for regenerative medicine. The high incidence of periodontitis, increasing prevalence of heart diseases and diabetes in the U.S., and growing number of research studies in Canada are the major factors supporting the growth of this market. The Asia-Pacific region is projected to register the highest growth rate during the forecast period.

Major Key Players Mapped in Research Report:

The major players operating in the global collagen market for regenerative medicine include Integra LifeSciences Holding Corporation (U.S.), Collagen Matrix, Inc. (U.S.), Collagen Solutions plc (U.K.), Royal DSM (Netherlands), Vornia Biomaterials, Ltd. (Ireland), SYMATESE (France), and NuCollagen, LLC. (U.S.). The major players operating in the global gelatin market for regenerative medicine include GELITA AG (Germany), Nitta Gelatin, Inc. (Japan), and PB Gelatin (Belgium).

The growth in this market is driven by technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and bio-pharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and the increasing incidence and prevalence of chronic and infectious diseases, single cell isolation market.

How the Market Growth looks like and Industry Segmentation?

The Single-cell Analysis Market is projected to reach USD 5.6 billion by 2025, at a CAGR of 17.8% during the forecast period.

The consumables segment accounted for the largest share of the single-cell analysis market, by product, in 2018

Based on product, the market is segmented into consumables (beads, microplates, reagents, assay kits, and other consumables) and instruments (flow cytometers, NGS systems, PCR instruments, spectrophotometers, microscopes, cell counters, HCS systems, microarrays, and other instruments). The consumables segment accounted for the largest market share in 2018. The large share of this segment can be attributed to the frequent purchase of these products as compared to instruments, which are considered as a one-time investment, and their wide applications in research and genetic exploration, exosome analysis, and isolation of RNA and DNA.

NGS is the fastest-growing segment of the single-cell analysis market, by technique

Based on technique, the market is segmented into flow cytometry, NGS, PCR, microscopy, mass spectrometry, single-cell rna sequencing and other techniques. The NGS segment is projected to register the highest growth rate of 20.0% during the forecast period. The high growth of the NGS segment is driven by the increasing application of single-cell analysis products in drug discovery for cancer and other chronic diseases.

Browse 225 market data Tables and 50 Figures spread through 252 Pages and in-depth TOC – Request Research Sample Pages: 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=171955254

 

 

Recent Developments:

• In November 2019, QIAGEN launched QIAseq Multimodal Panels, which have been developed for consolidated targeted DNA and RNA enrichment and analyses. These panels save time and conserve samples that are of limited availability.
• In July 2019, QIAGEN partnered with Illumina with the aim to broaden the availability and use of NGS-based in vitro diagnostic (IVD) kits.
• In June 2019, Beckman Coulter acquired Cytobank, Inc. (US) to integrate Cytobank’s software into Beckman Coulter’s product portfolio to provide innovative solutions to customers.
• In July 2018, 10x Genomics partnered with BioLegend to develop ready-to-use solutions for the simultaneous measurement of highly multiplexed proteins and unbiased gene expression from single cells.
• In March 2018, Danaher Corporation acquired Integrated DNA Technologies. This acquisition aimed at expanding Danaher’s presence in the highly attractive genomics market.

Geographical Regions Mapped in Report:

The global single-cell analysis market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the market. The growth in this market can be attributed to the increasing drug development activities in the pharmaceutical and biotechnology industries, rising prevalence of chronic and infectious diseases, and an increase in stem cell research activities.

Download PDF Brochure: 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171955254

Prominent players in the single-cell analysis market include Becton, Dickinson and Company (US), Danaher Corporation (US), Merck Millipore (US), QIAGEN (Netherlands), Thermo Fisher Scientific (US), General Electric Company (US), 10x Genomics (US), Promega Corporation (US), Illumina (US), Bio-Rad Laboratories (US), Fluidigm Corporation (US), Agilent Technologies (US), NanoString Technologies (US), Tecan Group (Switzerland), Sartorius AG (Germany), Luminex Corporation (US), Takara Bio (Japan), Fluxion Biosciences (US), Menarini Silicon Biosystems (Italy), and LumaCyte (US).

The study involved four major activities in estimating the current size of the breast reconstruction market. Exhaustive secondary research was conducted to collect information on the market and its different sub segments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub segments

How the market Growth Impact in terms of revenue?

The Global Breast Reconstruction Market size is projected to reach USD 603 million by 2025, at a CAGR of 7.0% during the forecast period.

Breast Reconstruction Market, Growth Factor Analysis:

·        Rising incidence of breast cancer

·        Increasing awareness

·        Reimbursements for breast reconstruction

·        Development of 3D-printed implants

Speak to Our Research Analyst, to resolve your Queries:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=186501593

Breast implants accounted for the largest share of the market

Based on the product, the breast reconstruction market is segmented into breast implants, tissue expanders, and acellular dermal matrix. The breast implants segment accounted for the largest market share in 2019.

The immediate procedures segment accounted for the largest market share in 2019.

Based on the procedure, the breast reconstruction market is segmented into immediate, delayed, and revision procedures. The immediate procedures segment accounted for the largest market share in 2019. This is primarily attributed to the increasing number of surgeries post-mastectomy and rising awareness.

Recent Developments

·        In 2019, Polytech Health & Aesthetics received US FDA approval for its textured breast implants (macrotextured and polyurethane-coated implants)

·        In 2018, J&J launched CPX4 breast tissue expander

·        In 2018, Polytech Health & Aesthetics merged with G&G Biotechnology

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186501593

By region, the breast reconstruction market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share, followed by Europe. This is attributed to factors such as the rising incidences of breast cancer, increasing awareness of breast reconstruction, and FDA approvals for breast reconstruction products

The prominent players operating in the global breast reconstruction market are Johnson & Johnson (US), Allergan (Ireland), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), Polytech Health & Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (Costa Rica), and Silimed (Brazil).

The Biobanking Market is expected to reach $2.69 billion, at a CAGR of 7.8%

Regenerative medicine applications for biobanking market will drive the market

Biobanking Market plays an integral role in advancing biomedical and translational research, through the collection and preservation of biological samples, such as blood, tissues, and nucleic acids, which are then made available for use in research to discover disease-relevant biomarkers; this is further used for diagnosis, prognosis, and predicting drug responses. Growth in the number of research activities in this segment forms a major driver for the  market. The availability of government funding for regenerative medicine, stem cell therapeutics, and cell & gene therapy is supporting research activities in this segment. Apart from this, the increasing trend of cord blood banking will also aid growth of this market segment. Future prospects including advancements in orthopedic procedures with the use of stem cells are expected to further support market growth for regenerative medicine.

Major Biobanking Market Developments

• In 2017, Brooks Automation, Inc. (U.S.) launched BioStore IIIv, BioStudies Biobank Data Management, FluidX, IntelliXcap Decapper systems to strengthen its product portfolio in biobanking segment.
• In 2016, Thermo Fisher Scientific Inc. (U.S.) entered into a partnership with Hamilton Storage (U.S.) to strengthened Thermo Fisher’s presence in the market.
• In 2015, Panasonic Healthcare Holdings (Japan) launched MDF-DU900V VIP -86°C Upright Freezer.

Browse 123 Market Data Tables and 38 Figures spread through 164 Pages and in-depth TOC – Request Research Sample Pages: 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=594

The equipment segment is expected to dominate the market.

By product and service, the biobanking market is segmented into equipment, consumables, services, and software. The equipment segment is expected to dominate the global biobanking market in 2017. Rising number of biobanks and the increasing number of biospecimens are factors increasing the demand for biobanking equipment.

Blood products are estimated to command the largest market share.

The biobanking market is segmented by sample type into blood products, human tissues, nucleic acids, human waste products, cell lines, and biological fluids. In 2017, the blood products segment is expected to account for the largest share of the biobanking market, by sample type. Rising incidence of blood disorders and the increasing demand for various types of blood products across the globe are driving the growth of this segment.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=594

Geographical Regions Mapped in Report:

Based on region, the biobanking market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is expected to dominate the biobanking market in 2017, this is attributed to factors like increasing research activities in regenerative medicine, cell and gene therapy; growing interest in personalized medicine and biomarker discovery; increasing number of biotechnology and pharmaceutical companies; and rising investments in genomics and proteomics research in the region as compared to other regions.

Major Key Players Mapped in Research Report:

Key players in the biobanking market include Thermo Fisher Scientific Inc. (U.S.), Tecan Group Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (U.S.), Brooks Automation (U.S.), TTP Labtech Ltd (U.K.), VWR Corporation (U.S.), Promega Corporation (U.S.), Worthington Industries [(Taylor Wharton, U.S.)],  Chart Industries (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Micronic (Netherlands)

The Global Cold Pain Therapy Market is projected to reach USD 2.12 billion by 2023 from USD 1.69 billion in 2018, at a CAGR of 4.6% during the forecast period.

The increasing incidence of sports injuries and rising emphasis on exercise and gym activities, growing number of hip and knee surgeries across the globe, and growing need for safer pain management modalities as opposed to oral drug therapy are expected to drive the demand for cold therapy products during the study period.

Recent Developments:

• In 2016,  Breg launched its VPULSE Therapy Product
• In 2018, Hisamitsu Pharmaceutical and Olympic and Paralympic Games,
  Tokyo 2020 entered into an agreement to be an official partner to provide external pain relief products during the 2020 Tokyo Olympic and Paralympic Games
• In July 2016, Breg and Novation (US), entered into a partnership. As per the partnership, members served by Novation will have access to improved pricing for Breg’s portfolio of cold therapy devices, sports bracing products, and soft goods dedicated to advancing orthopedic care.
•  In May 2016, Patterson Medical (US) acquired Performance Health (US)

Browse 106 market data Tables and 126 Figures spread through 273 Pages and in-depth TOC – Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=55543905

Market Segmentation in Depth:

The OTC products segment is expected to register the highest growth rate during the forecast period

Based on product, the cold pain therapy market is divided into OTC products and prescription products. OTC products are expected to grow at the highest CAGR during the forecast period. The high patient preference for topical pharmaceuticals as compared to oral medications, owing to their lower side effects, fast pain relief, and convenience, is expected to drive the growth of the OTC products segment in the next five years.

Musculoskeletal disorders are estimated to form the largest segment of the market, by application

The cold pain therapy market is segmented, by application, into musculoskeletal disorders, post-operative therapy, sports medicine, and post-trauma therapy. The musculoskeletal disorders segment is expected to account for the largest share of the cold pain therapy market in 2018, owing to the increasing incidence of arthritis, osteoarthritis, back pain, and joint pain; increasing trend of self-care; and the growing preference for topical analgesics to manage musculoskeletal pain.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55543905

Geographical Regions Mapped in Report:

Geographically, the cold pain therapy market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2017. The growing geriatric population, the high incidence of arthritis and sports injuries, product launches, the large number of surgeries, and stringent regulations on opioid prescription are expected to drive the growth of cold pain therapy products this region.

Maior Key Players Mapped in Research Report:

The major players of the market are Sanofi(France), Pfizer (US), Hisamitsu Pharmaceutical (Japan), Johnson & Johnson (US), Medline Industries (US), Össur (Iceland), Performance Health (US), Beiersdorf (Germany), Rohto Pharmaceutical (US), Breg (US), Romsons Group of Industries (India), Custom Ice (US), and Unexo Life Sciences (India) among others.

According to the new market research report “Track and Trace Solutions Market by Product (Plant Manager, Checkweigher, Barcode Scanner, Verification) Technology (2D Barcode, RFID) Application (Serialization, Aggregations, Reporting) End User (Pharmaceutical, Medical Devices) – Global Forecast” published by MarketsandMarkets™.

How the Market Growth looks like and Industry Segmentation?

The Track and Trace Solutions Market is projected to reach USD 4.21 billion by 2024 from USD 2.16 billion in 2019, at a CAGR of 14.2%.

Based on types of software, the track and trace solutions market is segmented into plant manager, line controller, enterprise & network manager, bundle tracking, warehouse & shipment manager, case tracking, and pallet tracking software. The plant manager segment accounted for the largest market share in 2018. The rising need to secure the supply chain of pharmaceutical and medical devices manufacturing industries along with strict government legislation are the key factors driving the growth of the plant manager segment.

Based on application, the track and trace solutions market is segmented into serialization, aggregation, and tracking, tracing, and reporting solutions. The tracking, tracing, & reporting solutions segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing number of regulations such as DSCSA, UDI, and Medical Device Reporting (MDR) for medical devices and pharmaceutical products.

Browse 264 market data Tables and 52 Figures spread through 300 Pages and in-depth TOC – Request Research Sample Pages: 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=158898570

Recent Developments in Industry:

• In 2018, Antares Vision launched its product, ATSFOUR, an enterprise-level serialization software solution. The new ATSFOUR integrates the Antares Tracking System architecture and offers a comprehensive solution which allows the widest connection capability for any traceability network.
• In 2018, Ropack Pharma Solutions (Canada) signed an agreement with TraceLink (US) in order to achieve DSCSA compliance for its pharmaceutical customers.
• In 2017, OPTEL Group (Canada) acquired Verify Brand LLC (US). The addition of Verify Brand’s L4/5 serialization capabilities to the OPTEL solution set enables the connectivity required for pharma companies to implement Track & Trace across the entire supply chain (L1 to L5).

Major Market Growth Drivers:

• Stringent Regulations & Standards for the Implementation of Serialization
• Increasing Focus of Manufacturers on Brand Protection
• Growth in the Number of Packaging-Related Product Recalls
• High Growth in the Generic and Otc Markets
• Growth in the Medical Device Industry

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158898570

North America accounted for the largest share of the track and trace solutions market in 2018, followed by Europe. Factors such as the presence of a large number of pharmaceutical & biotechnology companies and medical device manufacturers, stringent regulations regarding serialization, and the growing medical devices market, are driving the growth of the track and trace solutions market in North America.

Prominent players in the track and trace solutions market are OPTEL Group (Canada), Mettler-Toledo International Inc. (US), Systech International Inc. (US), TraceLink Inc. (US), Antares Vision (Italy), SAP (US), Xyntek Inc. (US), Adents International (France), SEA Vision Srl (Italy), Robert Bosch (Germany), Körber Medipak Systems AG (Switzerland), Siemens AG (Germany), Uhlmann Group (Germany), Jekson Vision (India), Videojet Technologies, Inc. (US), Zebra Technologies Corporation (US), Axway Inc. (US), NJM Packaging (US), rfxcel Corporation (US), ACG Worldwide (India), Laetus GmbH (Germany), WIPOTEC-OCS (Germany), Domino Printing Sciences plc (UK), Kevision Systems (India), Grant Soft (Turkey), SL Control Ltd. (US), and Arvato Bertelsmann (Germany).

The Global Lymphedema Diagnostics Market is projected to reach USD 35 million by 2024 from USD 24 million in 2019, at a CAGR of 7.4%.

The growing global prevalence of lymphedema and cancer; technological advancements in diagnostic imaging modalities; and increasing investments, funds, and grants by public-private organizations are the major factors driving the growth of this market.

Report Objectives:

• To define, describe, and forecast the market on the basis of technology, disease type, end user, and region
• To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
• To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the total market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

Browse 107 market data Tables and 30 Figures spread through 165 Pages and in-depth TOC – Request Research Sample Pages –https://www.marketsandmarkets.com/requestsampleNew.asp?id=145177203

Market Segmentation in Depth:

On the basis of disease type, the market is segmented into cancer, cardiovascular disease, inflammatory diseases, and other diseases. The cancer segment accounted for the largest share of the market in 2018. The large share of this segment can be attributed to the rising prevalence of cancer-associated lymphedema and increasing awareness about early disease diagnosis.

On the basis of end user, the market is segmented into hospitals, diagnostic centers, research & academic institutes, and other end users (pharmaceutical & biotechnology companies and CROs). The hospitals segment accounted for the largest share of the market in 2018. The large share of this segment can be attributed to the large number of lymphedema diagnostic procedures performed in hospitals, the growing adoption of minimally invasive procedures, and the rising adoption of advanced imaging modalities to improve workflow efficiency in hospitals.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145177203

Geographical Regions Mapped in Report:

The lymphedema diagnostics therapy market is segmented into four regional segments, namely, North America, Europe, the Asia Pacific, and the Rest of the World. The large share of North America can be attributed to factors such as the easy availability and rapid adoption of technologically advanced imaging systems; high incidence/prevalence of lymphedema; and the strong, well-established healthcare systems. The market in the Asia Pacific is expected to grow at the highest rate, followed by Europe.

Some key players mentioned in the research report are:

The major players operating in the lymphedema diagnostics market are GE Healthcare (US), Philips (Netherlands), and Siemens Healthineers (Germany). Other prominent players in this market include Canon, Inc. (Japan), Shimadzu Corporation (Japan), Stryker Corporation (US), Fluoptics (France), United Imaging Healthcare Co., Ltd. (China), Hitachi, Ltd. (Japan), Esaote, SpA (Italy), Neusoft Corporation (China), Mindray Medical International, Ltd. (China), Mitaka USA, Inc. (US), Curadel, LLC (US), and ImpediMed Ltd. (Australia).

The Laboratory Gas Generators Market is projected to reach USD 508 million, at a CAGR of 12.7% during the forecast period.

According to the new market research report “Laboratory Gas Generators Market by type (Nitrogen, Hydrogen, Zero Air, Purge Gas, ToC), Application (GC, LCMS, Gas Analyzer), Enduser (Pharma, Biotech, CRO, Chemical, Petrochemical, Food & Beverage, R&D, Environmental Companies) – Global Forecast” published by MarketsandMarkets™.

Recent Developments in Market;

• In May 2017, Peak Scientific announced the expansion of its regional office in Brazil.
• In November 2018, Praxair (US) signed an agreement with Phillips 66 (US) to supply high-purity hydrogen for Phillips’ 66 Sweeny Refinery
• In February 2017, NEL (Norway) acquired Proton Energy Systems Inc. (Proton Onsite) (US) to become the world’s largest supplier of products based on the Proton Exchange Membrane (PEM) technology.

Browse 83 market data Tables and 24 Figures spread through 123 Pages and in-depth TOC – Request Research Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=133302129

Market Segmentation in Depth:

The gas chromatography segment is expected to grow at the highest CAGR during the forecast period.

On the basis of application, the Laboratory Gas Generators Market is segmented into gas chromatography (GC), liquid chromatography-mass spectrometry (LC-MS), gas analyzers, and other applications [light scattering detectors, evaporators, microwave plasma-atomic emission spectrometers, and sample preparation instruments]. The GC segment is expected to grow at the highest CAGR during the forecast period, mainly due to its advantages such as convenience, safety, extended downtime, optimal analysis, and elimination of hazardous gas cylinders.

The pharmaceutical & biotechnology companies segment accounted for the largest share of the laboratory gas generators market in 2019.

On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, chemical & petrochemical companies, food & beverage companies, other end users (environmental companies and research & academic institutions). The pharmaceutical & biotechnology companies segment commanded the largest share of the market in 2018. Factors such as the rising demand for laboratory analytical instruments, rising drug research activities, stringent drug discovery regulations, and lab automation are contributing to the large share of this end-user segment.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=133302129

Geographical Regions Mapped in Report:

On the basis of region, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2018, North America accounted for the largest share of the market, followed by Europe. However, Asia is expected to grow at the highest CAGR during the forecast period. Market growth in this region is primarily driven due to the significant outsourcing of clinical trials to Asian countries, among other factors.

Who are the key players operating in the global lab gas generators market?

The laboratory gas generators market is a highly diversified and competitive market, with several large as well as emerging players. Players in the market include Parker Hannifin Corporation (US), Peak Scientific Instruments Ltd. (UK), Praxair Technology, Inc. (UK), Nel (Norway), F-DGSi (France), VICI DBS (US), LNI Swissgas Srl (Switzerland), LabTech S.r.l. (Italy), Claind S.r.l. (Italy), and ErreDue s.p.a. (Italy).

The term “cell signaling” is used to define the complex interactive system of signals that regulates and mediate various cellular responses in the human body.

Cell signaling is used to study signaling pathways of cells in drug discovery and therapeutic development, to distinguish drug resistance patterns in cancerous cells. It also identifies the major signaling pathways impacted by specific drug treatments. Cell signaling pathways—also called signal transduction pathways—act as connecting links between environmental stimuli and the corresponding cellular response. These signaling pathways mainly consist of proteins that can interact, move to specific locations, or be modified.

How the Market Growth looks like and Industry Segmentation?

The Cell Signaling Market is projected to reach USD 3.51 billion, at a CAGR of 6.8%

Based on product, the market is segmented into consumables and instruments. The cell signaling consumables segment is estimated to account for the largest share of the cell signaling market. The increasing number of cell signaling research activities and rising incidence of chronic diseases are some of the major factors contributing to the segments large market share.

By pathway, the cell signaling market is segmented into AMP-activated protein kinase (AMPK), Akt, ErbB/HER, Hedgehog (Hh), NF-êB, Janus kinase and signal transducer and activator of transcription (JAK/STAT), Notch, and other signaling pathways. The Akt pathway segment is estimated to account for the largest share of the market .

Based on signaling type, the market is segmented into paracrine, endocrine, autocrine, juxtacrine, and other signaling types (intracrine and neuronal signaling). The endocrine segment is estimated to account for the largest share of the cell signaling market

Browse 157 market data tables and 76 figures spread through 212 pages and in-depth TOC – Request Research Sample Pages: 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=80206120

Major Market Developments

• In 2016, Thermo Fisher Scientific Inc. (U.S.) acquired FEI Company (U.S.) to strengthen its high-performance electron Microscopy business.
• In 2017, Becton, Dickinson and Company (U.S.) launched BD Resolve Single-Cell Gene Expression platform. This has strengthen the position of company in cell signalling market.
• In 2016, Cell Signaling Technology Inc. (U.S.) launched CellSimple Cell Analyzer. This helped company to strengthen the presence in cell signalling market.

Major Market Growth Drivers:

• Rising Incidence of Chronic Diseases
• Availability of Funding for Cell-Based Research
• Technological Advancements in Cell-Based Research Instruments
• Growth of End-Use Industries

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80206120

Geographical Regions Mapped in Report:

On the basis of region, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is estimated to account for the largest share of the cell signaling market. Growth in this regional segment is driven by the growth in geriatric population, rising incidence of chronic diseases, and improved life science research infrastructure in the region.

Major Key Players Mapped in Research Report:

The key players in the cell signaling market include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.), QIAGEN N.V. (Netherlands), Cell Signaling Technology, Inc. (U.S.), Promega Corporation (U.S.), Bio-Techne Corporation (U.S.), Abcam plc (U.K.), Miltenyi Biotec (Germany), Full Moon BioSystems, Inc. (U.S.), Cell Biolabs, Inc. (U.S.)

MarketsandMarkets forecasts the Metabolomics Market to reach USD 2.38 billion, at a Compound Annual Growth Rate (CAGR) of 14.6% during the forecast period.

Metabolomics plays a vital role in the fields of toxicity testing, biomarker development, drug discovery, and clinical diagnostics. Factors such as the growing demand for personalized medicine, increasing pharmaceutical and biotech R&D expenditure, and rising necessity for toxicology testing are driving the growth of the metabolomics market.

Market Growth Opportunity:

Biomarker development;

Metabolomics is used for the identification of new biomarkers through the use of bioinformatics tools, which indicate the changes in the physiological state of a cell or tissue. Biomarkers are important for the development of in vitro diagnostic tools, environmental toxicology screening methods, and drug discovery and development techniques. The omics revolution of the last decade has increased the application of metabolomics in biomedical research. As a result of these technological developments, new biomarkers are being regularly discovered. These biomarkers are required in medical sciences to better define and diagnose diseases, predict adverse drug events, and identify patient groups who would benefit from certain treatments. Moreover, in the near future, the identification of biomarkers related to the safety, sensitivity, and resistance to commercially available drugs will present significant growth opportunities for the metabolomics market.

Browse 188 market data Tables and 42 Figures spread through 286 Pages and in-depth TOC – Request Research Sample Pages: 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=900

Market Segmentation in Depth:

On the basis of products & services, the metabolomics market is segmented into metabolomics instruments and bioinformatics tools and services. The metabolomics instruments segment commanded the largest share of the global market. This is mainly due to the ability of these instruments to separate and detect the complex structure of metabolites on a large scale, providing quality results. Furthermore, wide usage of these instruments in research activities, increase in funds for research projects, development of innovative technologies in these tools, and their extensive application in the drug discovery process are fueling the growth of this market.

Based on applications, the biomarker discovery segment accounted for the largest share of the global metabolomics market. The rising prevalence and incidence of chronic diseases such as cardiac diseases, cancer, and diabetes; growing acceptance of cancer diagnostic tests; and scientific progression in discovery technologies are major factors driving market growth in this segment.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=900

Geographical Regions Mapped in Report:

North America accounted for the largest share of the metabolomics market, followed by Europe. Easy accessibility to technologically advanced products and the presence of a large number of leading metabolomics manufacturers in the region are driving market growth in North America. Similarly, the rising acceptance of personalized medicines, increasing metabolomics research activities, and growing adoption of technologically advanced products are driving the growth of the North American metabolomics technology market.

Maior Key Players Mapped in Research Report:

Some key players in this market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Metabolon Inc. (U.S.), LECO Corporation (U.S.), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies, Inc. (Japan), and Waters Corporation (U.S.). These leading players have primarily focused on product launches, acquisitions, agreements, collaborations, partnerships, and expansions for growth in the market.